Turnstone Biologics Corp. Board of Directors

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, head and neck cancer and uveal melanoma, as well as an investigator sponsored trials to treat colorectal cancer, head and neck cancer, and cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.

Dr. Michael Fitch Ph.D.

Dr. Michael Fitch Ph.D.

Senior Vice President of Manufacturing

Dr. David Stojdl Ph.D.

Dr. David Stojdl Ph.D.

Senior Vice President of Research & Discovery

Ms. Wendy Worcester CFA, CPA

Ms. Wendy Worcester CFA, CPA

VP, Principal Finance & Accounting Officer

Dr. Ines Verdon M.D.

Dr. Ines Verdon M.D.

Senior Vice President of Clinical Development

Ms. Saryah Azmat

Ms. Saryah Azmat

Chief Operating Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.